Trading Update
September 02 2022 - 2:00AM
Trading Update
DXS INTERNATIONAL PLC
Trading Update
The Board of DXS International plc (“the
Company”), the AQSE Growth Market quoted healthcare information and
digital clinical decision support systems provider, is pleased to
announce that the Board is reviewing its growth plans for the next
24 months. The Company is seeking to accelerate its current market
expansion drive in both the UK and internationally and to support
the launch of its new advanced artificial intelligence clinical
decision support solution. The option to achieve a rapid expansion
of its customer base may require further investment in its sales,
marketing and development base. A further fund raise to increase
efforts in this area is under consideration, and ideally the
Company would like to raise up to but not limited to £1.5m in this
calendar year as a part of those plans, however no firm decisions
have yet been made in this regard.
In our recent annual report, we highlighted that
healthcare IT is moving at an unprecedented pace. The Covid-19
pandemic has added new impetus to the realisation that healthcare
delivery is urgently in need of a major overhaul and DXS, with deep
knowledge and experience in the electronic healthcare space, is
well-positioned to exploit this fast-emerging opportunity.
A further announcement will be made in due
course when plans have been finalised.
The Directors of DXS International plc accept
responsibility for this announcement.
Contacts :
David
Immelman 01252
719800DXS International plcwww.dxs-systems.com
AQSE Corporate BrokerHybridan
LLP 020 3764
2341Claire Louise Noyce
Corporate AdvisorCity &
Merchant 020 7101
7676David Papworth
Notes to Editors
About DXS:
DXS International presents up to date treatment
guidelines and recommendations, from Clinical Commissioning Groups
and other trusted NHS sources, to doctors, nurses and pharmacists
in their workflow and during the patient consultation. This
effective clinical decision support ultimately translates to
improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its
projected efficiency savings.
DXS (AQSE:DXSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
DXS (AQSE:DXSP)
Historical Stock Chart
From Jul 2023 to Jul 2024